December 22, 2016
Sumitomo Dainippon Pharma said on December 21 that it will acquire Tolero Pharmaceuticals, a US biotech startup specializing in cancer and hematologic disorders, for roughly US$200 million. “The deal will help us strengthen our pipeline in oncology, which is one...read more